Dental Bone Graft Substitutes Companies

Top Industry Leaders in the Dental Bone Graft Substitutes Market

Latest Dental Bone Graft Substitutes Companies Update

Jan 2023: By the agreement, Asahi Kasei Medical expands its bioprocess business by including a biopharmaceutical contractual development and production organization (CDMO). Bionova is a company that develops and produces treatments using recombinant proteins. The acquisition's closing is contingent upon receiving the necessary regulatory permissions. With over 100 workers, Bionova is a portfolio company of Great Point Partners, a private investment organization with its headquarters in Greenwich, Connecticut, concentrating on the healthcare sector. According to Asahi Kasei Medical, process development and GMP manufacturing operations are essential to the general business success of biopharma customers as well as the introduction of new medications. Bionova is well-known in the industry for its process development skills.

Nov 2023: In comparison to traditional spinal cord stimulation (SCS) therapy, patients with chronic back pain can see a considerable reduction in pain using Medtronic's differential target multiplexed (DTM) SCS therapy, according to study data released by the company. The 12-month trial, which involved 20 US facilities, compared Medtronic's DTM SCS program to traditional spinal cord stimulation therapy and discovered that patients with various degenerative conditions could experience much less pain using the DTM SCS program. The NOVA research was an open-label, prospective, multi-center experiment that aimed to enroll patients with non-surgically treated herniated disc (HD), degenerative disc disease (DDD), or radicular pain syndrome (RPS) and compare the DTM SCS system to traditional spinal cord stimulation.

List of Dental Bone Graft Substitutes Key companies in the market